These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3031857)

  • 1. Radioimmunoassay of urinary 3 beta-hydroxy-5-cholenoyl glycine in hepatobiliary disease.
    Yamauchi S; Kojima M; Nakayama F
    Steroids; 1986; 47(2-3):143-55. PubMed ID: 3031857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioimmunological determination of serum 3 beta-hydroxy-5-cholenoic acid in normal subjects and patients with liver disease.
    Minder EI; Karlaganis G; Paumgartner G
    J Lipid Res; 1979 Nov; 20(8):986-93. PubMed ID: 93138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A monoclonal antibody-based enzyme-linked immunosorbent assay of glycolithocholic acid sulfate in human urine for liver function test.
    Kobayashi N; Katsumata H; Uto Y; Goto J; Niwa T; Kobayashi K; Mizuuchi Y
    Steroids; 2002 Sep; 67(10):827-33. PubMed ID: 12231118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of serum bile acid radioimmunoassay in hepatobiliary diseases--with special reference to the CG/SLCG ratio (author's transl)].
    Oshiumi Y; Koga S; Kamoi I; Nishitani H; Ichiya Y; Ibayashi H; Matsuura K
    Radioisotopes; 1979 Oct; 28(10):630-5. PubMed ID: 531242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levels of immunoreactive glycine-conjugated bile acids in health and hepatobiliary disease.
    Demers LM; Hepner GW
    Am J Clin Pathol; 1976 Nov; 66(5):831-9. PubMed ID: 983991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioimmunoassay of bile acids in tissue, bile, and urine.
    Wildgrube HJ; Stockhausen H; Metz P; Mauritz G; Mahdawi R
    Clin Chem; 1983 Mar; 29(3):494-8. PubMed ID: 6825261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A enzymatic and fluorimetric determination of total bile acid sulfates in human urine.
    Amakasu H; Suzuki H; Miyakawa T; Ootsuki M; Goto Y
    Tohoku J Exp Med; 1986 Aug; 149(4):343-50. PubMed ID: 3465065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary 6 beta-hydroxycortisol excretion in Hong Kong Chinese patients with hepatocellular carcinoma and other chronic liver diseases.
    Ng MC; Young RP; Critchley JA; Leung NW; Lau JW; Li AK
    Cancer; 1996 Apr; 77(8):1427-33. PubMed ID: 8608525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The preparation and properties of a highly specific antiserum elicited with 3-dehydrocholylglycine 3-succinyl-bovine serum albumin conjugate.
    Orbán EC; Pál Z
    Int J Rad Appl Instrum B; 1986; 13(3):285-7. PubMed ID: 3771262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary excretion of bile acids in patients with obstructive jaundice and hepatocellular disease.
    Gregg JA
    Am J Clin Pathol; 1968 Mar; 49(3):404-9. PubMed ID: 5645097
    [No Abstract]   [Full Text] [Related]  

  • 11. Urinary 7alpha-hydroxy-3-oxochol-4-en-24-oic and 3-oxochola-4,6-dien-24-oic acids in infants with cholestasis.
    Kimura A; Suzuki M; Murai T; Kurosawa T; Tohma M; Sata M; Inoue T; Hoshiyama A; Nakashima E; Yamashita Y; Fujisawa T; Kato H
    J Hepatol; 1998 Feb; 28(2):270-9. PubMed ID: 9514540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum bile acids in hepatobiliary disease].
    Esquivel López A; González Espinola G; Gutiérrez Nava R; García Arreola RM
    Rev Gastroenterol Mex; 1982; 47(1):9-12. PubMed ID: 7100761
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical significance of measuring urinary sulfated bile acids in adult patients with hepatobiliary diseases.
    Nanashima A; Obatake M; Sumida Y; Abo T; Yamane Y; Nomura M; Yuhio I; Sawai T; Takeshita H; Hidaka S; Yasutake T; Nagayasu T
    Hepatogastroenterology; 2009; 56(90):299-302. PubMed ID: 19579586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfated and nonsulfated bile acids in urine, serum, and bile of patients with hepatobiliary diseases.
    Makino I; Hashimoto H; Shinozaki K; Yoshino K; Nakagawa S
    Gastroenterology; 1975 Mar; 68(3):545-53. PubMed ID: 1112456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation on serum bile acid levels in hepatobiliary disease (CG, SLCG measured by a radioimmunoassay) (author's transl)].
    Suzuki M; Imaeda T; Doi H
    Horumon To Rinsho; 1979 Nov; 27(11):1319-26. PubMed ID: 519890
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical significance of serum and urinary neopterin levels in patients with various liver diseases.
    Daito K; Suou T; Kawasaki H
    Am J Gastroenterol; 1992 Apr; 87(4):471-6. PubMed ID: 1313206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of serum bile acids in hepatobiliary diseases. Clinical applicability].
    Pagani A; Pranzo A; Galante T
    Minerva Med; 1984 Jan; 75(3-4):99-107. PubMed ID: 6700830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary bile acids as biomarkers for liver diseases II. Signature profiles in patients.
    Bathena SP; Thakare R; Gautam N; Mukherjee S; Olivera M; Meza J; Alnouti Y
    Toxicol Sci; 2015 Feb; 143(2):308-18. PubMed ID: 25344563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The identification of urinary bile alcohols by gas chromatography-mass spectrometry in patients with liver disease and in healthy individuals.
    Ludwig-Köhn H; Henning HV; Sziedat A; Matthaei D; Spiteller G; Reiner J; Egger HJ
    Eur J Clin Invest; 1983 Feb; 13(1):91-8. PubMed ID: 6409629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary bile acid profile in children with inborn errors of bile acid metabolism and chronic cholestasis; screening technique using electrospray tandem mass-spectrometry (ES/MS/MS).
    Yousef IM; Perwaiz S; Lamireau T; Tuchweber B
    Med Sci Monit; 2003 Mar; 9(3):MT21-31. PubMed ID: 12640349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.